Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
复制标题
DOI:
10.1038/nature13117
复制
发表时间:
2014-05-15
期刊:
影响因子:
64.8
通讯作者:
Marcotrigiano, Joseph
中科院分区:
文献类型:
--
作者:
Khan, Abdul Ghafoor;Whidby, Jillian;Miller, Matthew T.;Scarborough, Hannah;Zatorski, Alexandra V.;Cygan, Alicja;Price, Aryn A.;Yost, Samantha A.;Bohannon, Caitlin D.;Jacob, Joshy;Grakoui, Arash;Marcotrigiano, Joseph
Hepatitis C virus (HCV) is a significant public health concern with approximately 160 million people infected worldwide . HCV infection often results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. No vaccine is available and current therapies are effective against certain, but not all, genotypes. HCV is an enveloped virus with two surface glycoproteins (E1 and E2). E2 binds to the host cell through interactions with scavenger receptor class B type I (SR-BI) and CD81, and serves as a target for neutralizing antibodies . Little is known about the molecular mechanism that mediates cell entry and membrane fusion, although E2 is predicted to be a class II viral fusion protein. Here we describe the structure of the E2 core domain in complex with an Fab at 2.4 Å resolution. The E2 core has a compact, globular domain structure, consisting mostly of beta strands and random coil with two small alpha helices. The strands are arranged in two, perpendicular sheets (A and B), which are held together by an extensive hydrophobic core and disulfide bonds. Sheet A has an IgG-like fold that is commonly found in viral and cellular proteins while sheet B represents a novel fold. Solution-based studies demonstrate that the full-length E2 ectodomain has a similar globular architecture and does not undergo significant conformational or oligomeric rearrangements upon exposure to low pH. Thus, the IgG-like fold is the only feature that E2 shares with class II membrane fusion proteins. These results provide unprecedented insights into HCV entry and will assist in developing an HCV vaccine and new inhibitors.
登录
查看更多内容
影响因子:
6.7
作者:
Krey T;d'Alayer J;Kikuti CM;Saulnier A;Damier-Piolle L;Petitpas I;Johansson DX;Tawar RG;Baron B;Robert B;England P;Persson MA;Martin A;Rey FA
通讯作者:
Rey FA
影响因子:
4.8
作者:
Drummer, HE;Poumbourios, P
通讯作者:
Poumbourios, P
影响因子:
6.1
作者:
Kozin, MB;Svergun, DI
通讯作者:
Svergun, DI
DOI:
10.1107/s0907444909052925
发表时间:
2010-02
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
Adams PD;Afonine PV;Bunkóczi G;Chen VB;Davis IW;Echols N;Headd JJ;Hung LW;Kapral GJ;Grosse-Kunstleve RW;McCoy AJ;Moriarty NW;Oeffner R;Read RJ;Richardson DC;Richardson JS;Terwilliger TC;Zwart PH
通讯作者:
Zwart PH
DOI:
10.1126/science.1243876
发表时间:
2013-11-29
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Kong L;Giang E;Nieusma T;Kadam RU;Cogburn KE;Hua Y;Dai X;Stanfield RL;Burton DR;Ward AB;Wilson IA;Law M
通讯作者:
Law M